Passage Bio Inc (PASG) financials · $25.2M cap
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Passage Bio Inc (PASG) $25.2M cap.
| Line | FY2025 | FY2024 | Pro (2 older periods with Lician Pro) |
|---|---|---|---|
| Operating Income | −$49.30M | −$70.40M | |
| Net Income | −$45.52M | −$64.77M | |
| EPS (Diluted) | −$14.35 | −$1.07 | |
| Unlock 5 years of statements: Lician Pro $149/yr | |||
| Line | FY2025 | FY2024 | Pro (3 older periods with Lician Pro) |
|---|---|---|---|
| Total Assets | $62.28M | $102.41M | |
| Current Assets | $47.76M | $78.81M | |
| Cash & Equivalents | $46.30M | $37.57M | |
| PP&E | $4.11M | $9.33M | |
| Total Liabilities | $43.53M | $41.15M | |
| Current Liabilities | $23.08M | $19.36M | |
| Shareholders' Equity | $18.75M | $61.26M | |
| Retained Earnings | −$704.76M | −$659.24M |
| Line | FY2025 | FY2024 | Pro (2 older periods with Lician Pro) |
|---|---|---|---|
| Operating Cash Flow | −$31.51M | −$47.96M | |
| CapEx | — | $34.00K | |
| Investing Cash Flow | $40.22M | $54.95M | |
| Financing Cash Flow | $23.00K | $8.87M | |
| Net Change in Cash | $8.73M | $15.86M | |
| Free Cash Flow | — | −$47.99M |
Source: Company filings with the SEC (EDGAR) · Latest period FY2025
FAQ
What is PASG P/E and revenue?
Passage Bio Inc (PASG) $25.2M cap.
What is PASG revenue?
PASG income-statement cache has no revenue figure yet.
Is PASG profitable?
Passage Bio Inc last cached net income is -$45.5M (FY2025).
What are PASG total assets?
Passage Bio Inc last cached total assets are $62.3M (FY2025).
What is PASG free cash flow?
No cached cash-flow row for PASG yet.
Not investment advice. Figures as reported in company filings, not a live feed.